The new United States Preventive Services Task Force (USPSTF) Breast Cancer Screening Recommendations are a step in the right direction. However, the American College of Radiology (ACR) and Society of Breast Imaging (SBI) urge the USPSTF to go further to recommend annual mammography screening for all average-risk women ages 40 and older.

Getty Images


May 12, 2023 — The new United States Preventive Services Task Force (USPSTF) Breast Cancer Screening Recommendations are a step in the right direction. However, the American College of Radiology (ACR) and Society of Breast Imaging (SBI) urge the USPSTF to go further to recommend annual mammography screening for all average-risk women ages 40 and older. 

The USPSTF, ACR, SBI, American Cancer Society and others all agree that the most lives are saved with this annual approach. Medical experts should clear the confusion caused by differing recommendations and agree to recommend yearly mammography for average-risk women starting at age 40. 

Mounting evidence shows that Black and other minority women, Jewish women, and others develop and die from breast cancer prior to age 50 — or even age 40 — more often than white women. As our 2021 guidelines for average-risk women and our new (2023) guidelines for high-risk women make clear, potentially giving cancer another year to advance may particularly impact these women. 

The ACR and SBI also recommend that all women have a risk assessment by age 25, as called for in new ACR/SBI guidelines for high-risk women and discuss with their doctor whether earlier screening with mammography and/or MRI is needed. 

Involving factors such as sex assigned at birth, hormone use and surgical histories place transgender persons at increased risk for breast cancer. Biological females transitioning to male who do not undergo mastectomy remain at their previous risk for breast cancer and should continue to be screened as such.  

As outlined in current (2021) ACR/SBI recommendations for average-risk women, due to hormone use, biological males transitioning to female are at increased risk for breast cancer compared to other males and should speak with their doctor about their breast cancer risk. 

The societies also recommend that women continue screening past age 74, unless severe comorbidities limit life expectancy. 

For more information: www.acr.org 

 

Related USPSTF Screening Recommendations Content: 

Task Force Issues New Draft Recommendation Statement on Screening for Breast Cancer 

Hologic Statement on Recently Released USPSTF Breast Cancer Screening Guidelines 

 

Related Breast Density Content: 

VIDEO: Research and Advancements in Breast Imaging Technology 

VIDEO: FDA Update on the US National Density Reporting Standard - A Discussion on the Final Rule 

One on One … with Wendie Berg, MD, PhD, FACR, FSBI 

Creating Patient Equity: A Breast Density Legislative Update 

FDA Needs to Ensure that Information on Dense Breast Notifications are Clear and Understandable to all Members of the Public 

AI Provides Accurate Breast Density Classification 

VIDEO: The Impact of Breast Density Technology and Legislation 

VIDEO: Personalized Breast Screening and Breast Density 

VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference 

Fake News: Having Dense Breast Tissue is No Big Deal 

The Manic World of Social Media and Breast Cancer: Gratitude and Grief 

 

Related Breast Imaging Content: 

Single vs. Multiple Architectural Distortion on Digital Breast Tomosynthesis 

Today's Mammography Advancements  

Digital Breast Tomosynthesis Spot Compression Clarifies Ambiguous Findings  

AI DBT Impact on Mammography Post-breast Therapy  

ImageCare Centers Unveils PINK Better Mammo Service Featuring Profound AI  

Radiologist Fatigue, Experience Affect Breast Imaging Call Backs  

Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography 

Study Finds Racial Disparities in Access to New Mammography Technology 

American College of Radiology (ACR) Launches Contrast-Enhanced Mammography Imaging Screening Trial (CMIST) in Collaboration With GE Healthcare and the Breast Cancer Research Foundation


Related Content

Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time April 15, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Dose Management

April 11, 2024 — Prelude Corporation (PreludeDx), a leader in precision diagnostics for early-stage breast cancer ...

Time April 11, 2024
arrow
News | Mammography

April 11, 2024 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention of ...

Time April 11, 2024
arrow
News | Society of Breast Imaging (SBI)

April 11, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced today ...

Time April 11, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
News | Ultrasound Imaging

April 9, 2024 — A new Society of Radiologists in Ultrasound (SRU) expert consensus statement to improve endometriosis ...

Time April 09, 2024
arrow
News | Artificial Intelligence

April 9, 2024 —PreciseDx, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for ...

Time April 09, 2024
arrow
News | Breast Imaging

April 8, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, is proud to ...

Time April 08, 2024
arrow
Subscribe Now